title: Why an M1 Antagonist Could Be a More Selective Model for Memory Impairment than Scopolamine.
authors.affiliation: Maastricht University , Maastricht , Netherlands.
authors.forename: Arjan
authors.initials: A
authors.lastname: Blokland
authors.affiliation: Maastricht University , Maastricht , Netherlands.
authors.forename: Anke
authors.initials: A
authors.lastname: Sambeth
authors.affiliation: Maastricht University , Maastricht , Netherlands.
authors.forename: Jos
authors.initials: J
authors.lastname: Prickaerts
authors.affiliation: Maastricht University , Maastricht , Netherlands.
authors.forename: Wim J
authors.initials: WJ
authors.lastname: Riedel
keywords: Alzheimer; actelylcholine; cognition enhancer; deficit model; memory